Activation of Soluble Guanylate Cyclase Causes Relaxation of Corpus Cavernosum Tissue: Synergism of Nitric Oxide and YC-1

Total Page:16

File Type:pdf, Size:1020Kb

Activation of Soluble Guanylate Cyclase Causes Relaxation of Corpus Cavernosum Tissue: Synergism of Nitric Oxide and YC-1 International Journal of Impotence Research (2002) 14, 121–127 ß 2002 Nature Publishing Group All rights reserved 0955-9930/02 $25.00 www.nature.com/ijir Activation of soluble guanylate cyclase causes relaxation of corpus cavernosum tissue: synergism of nitric oxide and YC-1 M Nakane1*, G Hsieh1, LN Miller1, R Chang1, MA Terranova1, RB Moreland1, T Kolasa1 and JD Brioni1 1Neuroscience, Global Pharmaceutical Research, Abbott Laboratories, Abbott Park, Illinois, USA Nitric oxide (NO) activates corpus cavernosum smooth muscle soluble guanylate cyclase (sGC) and increases the synthesis of cGMP that results in smooth muscle relaxation and ultimately, penile erection. To characterize sGC and define the potential synergy between NO and the allosteric activator YC-1 in corpus cavernosum, rat sGC was activated by either sodium nitroprusside (SNP) or YC-1, and YC-1 potentiated the effects of SNP with a 200-fold activation of sGC. Both SNP and YC-1 decreased the Km and increased the Vmax. ODQ significantly inhibited sGC activated by SNP with IC50 of 0.5 nM, but did not affect the sGC activated by YC-1 as well as basal sGC activity. SNP and YC-1 synergistically increased intracellular cGMP levels in rabbit corpus cavernosum smooth muscle cell cultures. YC-1 significantly relaxed rabbit cavernosum tissue strips in organ baths with an EC50 of 8.4 mM. In the presence of L-nitroarginine methyl ester to block endogenous NO production, co-administration of SNP shifted the dose response of YC-1 to the left, showing the synergism of SNP and YC-1 in tissue strips. In view of the clinical efficacy of phosphodiesterase-5 inhibitors, activation of sGC may provide an alternative means for enhancing the activity of neurally derived NO during sexual stimulation in the corpus cavernosum, representing a novel approach for the treatment of erectile dysfunction. International Journal of Impotence Research (2002) 14, 121–127. DOI: 10.1038=sj=ijir=3900843 Keywords: guanylate cyclase; activator; nitric oxide; YC-1; sodium nitroprusside; corpus cavernosum Introduction cGMP. On the other hand, NO or NO donors including nitroglycerine and sodium nitroprusside (SNP) are well-known sGC activators. Nitric oxide (NO), a key neurotransmitter mediating A novel type of sGC activators is represented by penile erection, exerts its effects by activating YC-1.3 This agent is not an NO donor, but causes corpus cavernosum smooth muscle soluble guany- activation of sGC especially in the presence of 1,2 late cyclase (sGC). sGC is responsible for the NO.4,5 The finding that YC-1 activates sGC by enzymatic conversion of GTP to cyclic GMP (cGMP), binding to an allosteric site on the enzyme opened and the increase of cGMP mediates relaxation the possibility to discover a new class of compounds of cavernosal smooth muscle leading to penile with a different pharmacological profile in compar- erection. ison to the NO donors. The goal of this study was to The discovery that NO-sGC-cGMP system is one characterize sGC and define the potential synergy of the major effectors in penile smooth muscle between NO and the allosteric activator YC-1 in relaxation has led to the development of two classes corpus cavernosum, and to discuss the possibility of agents that increase cGMP levels in cavernosal that the regulation of sGC by activators may smooth muscle: (a) agents that inhibit cGMP represent a new approach for the treatment of degradation (phosphodiesterase inhibitors); and (b) erectile dysfunction. agents that elevate cGMP synthesis (sGC activators). The latter class can be divided into NO-dependent and NO-independent sGC activators. Sildenafil increases cGMP levels by inhibiting Materials and methods phosphodiesterase-5, the enzyme that degrades Chemicals *Correspondence: M Nakane, D4ND, AP9, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064- 0 0 6119, USA. YC-1 (3-(5 -hydroxymethyl-2 -furyl)-1-benzyl inda- E-mail: [email protected] zole), ODQ (1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin- Received 31 August 2001; revised 20 December 2001; 1-one), L-NAME (No-nitro-L-arginine methyl ester) accepted 11 January 2002 and SNP (sodium nitroprusside) were purchased Activation of guanylate cyclase causes relaxation of cavernosal smooth muscle M Nakane et al 122 from Sigma RBI (St Louis, MO, USA), and GTP sGC expression obtained from Roche Molecular Biochemicals (In- dianapolis, IN, USA). Oligonucleotides were synthe- The cells were grown to 26106 cells=ml and then sized and purified in-house. Other reagents were infected with a mixture of the virus stocks for the a1- obtained from Sigma, otherwise indicated. and b1-subunits for protein production. We found that the best expression of sGC activity was achieved by a multiplicity of infection of 0.1 pfu each sGC expression in human corpus cavernosum subunit=cell and the three days incubation at 28C. Cells were harvested and stored at 7 80C. The cell To identify the sGC isoforms expressed in human pellets were thawed on ice and were homogenized penile corpus cavernosum, reverse transcriptase- with Tekmer Sonic Disruptor (Cincinnati, OH, USA) polymerase chain reaction (RT-PCR) analysis was in 5 vol of 20 mM Tris – HCl (pH 7.6) containing performed. Human penile corpus cavernosum tis- 1 mM EDTA, 5 mM dithiothreitol, 90 mM NaCl, 10% sues were obtained from Zoion Diagnostics (Shrews- glycerol, and 1 Protease Inhibitor Cocktail Tablet per bury, MA, USA). Total RNA was isolated using every 50 ml (Roche Molecular Biochemicals, India- TRIzol reagent (Life Technologies). Five micrograms napolis, IN, USA). The homogenate was centrifuged of total RNA was reverse-transcribed in a 20 ml at 50000 g for 30 min, and the supernatant was used reaction mixture containing 500 ng of oligo(dT)12 – 18, for GC purification. Purification was performed from 0.5 mM deoxynucleoside triphosphates, 10 mM 3 l culture of High5 cells as described previously,9 dithiothreitol, 5 mM MgCl2, 40 units RNase inhibitor and the purified preparation was aliquoted and in RT reaction buffer and 50 units of SuperScript II stored at 7 80C until use. RT (Life Technologies) at 42C for 50 min. PCR reactions were carried out in a 50 ml reaction mixture containing 0.2 mM deoxynucleoside triphosphates, GC enzyme assay 1.5 mM MgCl2, 20 nM of specific primers, cDNA, and two units of Taq DNA polymerase in PCR GC enzyme activity assay was performed as de- reaction buffer (Life Technologies). Amplified pro- scribed previously with modifications to allow us to ducts were resolved on a 1% agarose gel containing assay large number of samples at the same time.7 ethidium bromide. The following PCR primer pairs Assay mixtures contained 50 mM Tris – HCl (pH and conditions were used: sGC a1 subunit (488 bp 7.6), 4 mM MgCl2, 5 mM creatin phosphate, 0.5 mM product), 50-TGC CTC CCT GCT TCC ATA AT-30 IBMX, 4 units=ml creatin kinase and 1 mM GTP in a (sense) and 50-GTA GAG CCC TCG TCC TGT AAA volume of 100 ml in 96-well plate (Thermowell) 0 ATC-3 (antisense); sGC a2 subunit (392 bp product), (Costar, Corning, NY, USA). The incubation was 50-TGT ACA CCA GAT TTG ACC ACC AGT-30 carried out for 10 min at 37C followed by 95C for (sense) and 50-ACG AGA CCG CGG AAT GAA TG- 2 min to terminate the reaction using GeneAmp PCR 0 0 3 (antisense); sGC b1 subunit (846 bp product), 5 - System 9600 (PE Biosystems, Foster City, CA, USA). TAA GAG CCC TGG AAG ATG AAA AGA-30 (sense) Produced cGMP from GTP was quantified by and 50-TGG GGT AAT GGA CAA GGA CAA A-30 enzyme immunoassay (Amersham Pharmacia Bio- 0 (antisense); sGC b2 subunit (460 bp product), 5 -AGG tech, Piscataway, NJ, USA). GAA GAA GGA GCA TGT TGT GTT-30 (sense) and 50-TCT GCG GAT GCT GAA AAT GTT GA-30 (antisense).1 Samples were denatured at 94C for cGMP measurement in smooth muscle cell culture 30 s, followed by 30 cycles at 94C for 30 s, 55C for 30 s, and 72C for 60 s. Corpus cavernosal smooth muscle tissues were prepared from adult male New Zealand white rabbits (Covance Research Production, Kalamazoo, Recombinant baculovirus MI, USA). Explant cavernosal tissues were placed in small petri dishes in Dulbecco’s Modified Eagle 6,7 Rat sGC a1-andb1-subunits were subcloned into Medium containing 10% fetal bovine serum, anti- pVL1392 (Invitrogen, Carlsbad, CA, USA) and pre- biotics, and amphotercin B. The explants were kept pared recombinant baculoviruses encoding the a1 undisturbed for 3 – 4 days in 37 C5%CO2 incuba- 8 and the b1 subunits of sGC by the standard protocol. tor. Smooth muscle cells migrated out from the tissues underwent proliferation within 7 days. The explants were removed and the medium was Insect cell culture changed every 3 days. Once confluent, cells were detached with trypsin – EDTA and sub-cultured at a Sf9 or High5 cells were grown in suspension culture density of 0.56104 cells=well in 24-well culture in flasks or roller bottles at 28C. SF900II serum-free plates. All experiments were performed in caverno- medium (Life Technologies) was used for culture sum cells that had been grown for 48 h ( > 90% without any supplements. confluent). International Journal of Impotence Research Activation of guanylate cyclase causes relaxation of cavernosal smooth muscle M Nakane et al 123 The culture medium was changed and washed Results with Hank’s BSS solution three times immediately before each experiment. The cells were incubated with pharmacological agents with or without To characterize sGC expressed in human corpus 100 mM IBMX prepared in Hank’s BSS for 10 min. cavernosum, RNA was extracted from tissue sam- Cells were lysed with 0.5% (w=v) dodecyl triammo- ples obtained from eight patients and RT-PCR was nium bromide in 50 mM sodium acetate buffer (pH performed.
Recommended publications
  • Nitric Oxide in Health and Disease of the Nervous System H-Y Yun1,2, VL Dawson1,3,4 and TM Dawson1,3
    Molecular Psychiatry (1997) 2, 300–310 1997 Stockton Press All rights reserved 1359–4184/97 $12.00 PROGRESS Nitric oxide in health and disease of the nervous system H-Y Yun1,2, VL Dawson1,3,4 and TM Dawson1,3 Departments of 1Neurology; 3Neuroscience; 4Physiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA Nitric oxide (NO) is a widespread and multifunctional biological messenger molecule. It mediates vasodilation of blood vessels, host defence against infectious agents and tumors, and neurotransmission of the central and peripheral nervous systems. In the nervous system, NO is generated by three nitric oxide synthase (NOS) isoforms (neuronal, endothelial and immunologic NOS). Endothelial NOS and neuronal NOS are constitutively expressed and acti- vated by elevated intracellular calcium, whereas immunologic NOS is inducible with new RNA and protein synthesis upon immune stimulation. Neuronal NOS can be transcriptionally induced under conditions such as neuronal development and injury. NO may play a role not only in physiologic neuronal functions such as neurotransmitter release, neural development, regeneration, synaptic plasticity and regulation of gene expression but also in a variety of neurological disorders in which excessive production of NO leads to neural injury. Keywords: nitric oxide synthase; endothelium-derived relaxing factor; neurotransmission; neurotoxic- ity; neurological diseases Nitric oxide is probably the smallest and most versatile NO synthases isoforms and regulation of NO bioactive molecule identified. Convergence of multi- generation disciplinary efforts in the field of immunology, cardio- vascular pharmacology, chemistry, toxicology and neu- NO is formed by the enzymatic conversion of the guan- robiology led to the revolutionary novel concept of NO idino nitrogen of l-arginine by NO synthase (NOS).
    [Show full text]
  • Nitric Oxide Produced by Ultraviolet-Irradiated Keratinocytes Stimulates Melanogenesis
    Nitric oxide produced by ultraviolet-irradiated keratinocytes stimulates melanogenesis. C Roméro-Graillet, … , J P Ortonne, R Ballotti J Clin Invest. 1997;99(4):635-642. https://doi.org/10.1172/JCI119206. Research Article Ultraviolet (UV) radiation is the main physiological stimulus for human skin pigmentation. Within the epidermal-melanin unit, melanocytes synthesize and transfer melanin to the surrounding keratinocytes. Keratinocytes produce paracrine factors that affect melanocyte proliferation, dendricity, and melanin synthesis. In this report, we show that normal human keratinocytes secrete nitric oxide (NO) in response to UVA and UVB radiation, and we demonstrate that the constitutive isoform of keratinocyte NO synthase is involved in this process. Next, we investigate the melanogenic effect of NO produced by keratinocytes in response to UV radiation using melanocyte and keratinocyte cocultures. Conditioned media from UV-exposed keratinocytes stimulate tyrosinase activity of melanocytes. This effect is reversed by NO scavengers, suggesting an important role for NO in UV-induced melanogenesis. Moreover, melanocytes respond to NO-donors by decreased growth, enhanced dendricity, and melanogenesis. The rise in melanogenesis induced by NO-generating compounds is associated with an increased amount of both tyrosinase and tyrosinase-related protein 1. These observations suggest that NO plays an important role in the paracrine mediation of UV-induced melanogenesis. Find the latest version: https://jci.me/119206/pdf Nitric Oxide Produced by Ultraviolet-irradiated Keratinocytes Stimulates Melanogenesis Christine Roméro-Graillet, Edith Aberdam, Monique Clément, Jean-Paul Ortonne, and Robert Ballotti Institut National de la Santé et de la Recherche Médicale U385, Faculté de Médecine, 06107 Nice cedex 02, France Abstract lin-1 (ET-1),1 and GM-CSF by keratinocytes is upregulated after UV light exposure, and these peptides stimulate melanocyte Ultraviolet (UV) radiation is the main physiological stimu- growth (16–19).
    [Show full text]
  • Soluble Guanylate Cyclase B1-Subunit Expression Is Increased in Mononuclear Cells from Patients with Erectile Dysfunction
    International Journal of Impotence Research (2006) 18, 432–437 & 2006 Nature Publishing Group All rights reserved 0955-9930/06 $30.00 www.nature.com/ijir ORIGINAL ARTICLE Soluble guanylate cyclase b1-subunit expression is increased in mononuclear cells from patients with erectile dysfunction PJ Mateos-Ca´ceres1, J Garcia-Cardoso2, L Lapuente1, JJ Zamorano-Leo´n1, D Sacrista´n1, TP de Prada1, J Calahorra2, C Macaya1, R Vela-Navarrete2 and AJ Lo´pez-Farre´1 1Cardiovascular Research Unit, Cardiovascular Institute, Hospital Clı´nico San Carlos, Madrid, Spain and 2Urology Department, Fundacio´n Jime´nez Diaz, Madrid, Spain The aim was to determine in circulating mononuclear cells from patients with erectile dysfunction (ED), the level of expression of endothelial nitric oxide synthase (eNOS), soluble guanylate cyclase (sGC) b1-subunit and phosphodiesterase type-V (PDE-V). Peripheral mononuclear cells from nine patients with ED of vascular origin and nine patients with ED of neurological origin were obtained. Fourteen age-matched volunteers with normal erectile function were used as control. Reduction in eNOS protein was observed in the mononuclear cells from patients with ED of vascular origin but not in those from neurological origin. Although sGC b1-subunit expression was increased in mononuclear cells from patients with ED, the sGC activity was reduced. However, only the patients with ED of vascular origin showed an increased expression of PDE-V. This work shows for the first time that, independently of the aetiology of ED, the expression of sGC b1-subunit was increased in circulating mononuclear cells; however, the expression of both eNOS and PDE-V was only modified in the circulating mononuclear cells from patients with ED of vascular origin.
    [Show full text]
  • Structural Perspectives on the Mechanism of Soluble Guanylate Cyclase Activation
    International Journal of Molecular Sciences Review Structural Perspectives on the Mechanism of Soluble Guanylate Cyclase Activation Elizabeth C. Wittenborn and Michael A. Marletta * California Institute for Quantitative Biosciences, Departments of Chemistry and of Molecular and Cell Biology, University of California, Berkeley, CA 94720, USA; [email protected] * Correspondence: [email protected] Abstract: The enzyme soluble guanylate cyclase (sGC) is the prototypical nitric oxide (NO) receptor in humans and other higher eukaryotes and is responsible for transducing the initial NO signal to the secondary messenger cyclic guanosine monophosphate (cGMP). Generation of cGMP in turn leads to diverse physiological effects in the cardiopulmonary, vascular, and neurological systems. Given these important downstream effects, sGC has been biochemically characterized in great detail in the four decades since its discovery. Structures of full-length sGC, however, have proven elusive until very recently. In 2019, advances in single particle cryo–electron microscopy (cryo-EM) enabled visualization of full-length sGC for the first time. This review will summarize insights revealed by the structures of sGC in the unactivated and activated states and discuss their implications in the mechanism of sGC activation. Keywords: nitric oxide; soluble guanylate cyclase; cryo–electron microscopy; enzyme structure Citation: Wittenborn, E.C.; Marletta, 1. Introduction M.A. Structural Perspectives on the Soluble guanylate cyclase (sGC) is a nitric oxide (NO)-responsive enzyme that serves Mechanism of Soluble Guanylate as a source of the secondary messenger cyclic guanosine monophosphate (cGMP) in Cyclase Activation. Int. J. Mol. Sci. humans and other higher eukaryotes [1]. Upon NO binding to sGC, the rate of cGMP 2021, 22, 5439.
    [Show full text]
  • Potential Roles of Nitrate and Nitrite in Nitric Oxide Metabolism in the Eye Ji Won Park1, Barbora Piknova1, Audrey Jenkins2, David Hellinga2, Leonard M
    www.nature.com/scientificreports OPEN Potential roles of nitrate and nitrite in nitric oxide metabolism in the eye Ji Won Park1, Barbora Piknova1, Audrey Jenkins2, David Hellinga2, Leonard M. Parver3 & Alan N. Schechter1* Nitric oxide (NO) signaling has been studied in the eye, including in the pathophysiology of some eye diseases. While NO production by nitric oxide synthase (NOS) enzymes in the eye has been − characterized, the more recently described pathways of NO generation by nitrate ( NO3 ) and nitrite − (NO2 ) ions reduction has received much less attention. To elucidate the potential roles of these pathways, we analyzed nitrate and nitrite levels in components of the eye and lacrimal glands, primarily in porcine samples. Nitrate and nitrite levels were higher in cornea than in other eye parts, while lens contained the least amounts. Lacrimal glands exhibited much higher levels of both ions compared to other organs, such as liver and skeletal muscle, and even to salivary glands which are known to concentrate these ions. Western blotting showed expression of sialin, a known nitrate transporter, in the lacrimal glands and other eye components, and also xanthine oxidoreductase, a nitrate and nitrite reductase, in cornea and sclera. Cornea and sclera homogenates possessed a measurable amount of nitrate reduction activity. These results suggest that nitrate ions are concentrated in the lacrimal glands by sialin and can be secreted into eye components via tears and then reduced to nitrite and NO, thereby being an important source of NO in the eye. Te NO generation pathway from L-arginine by endogenous NOS enzymes under normoxic conditions has been central in identifying the physiological roles of NO in numerous biological processes1.
    [Show full text]
  • Nitric Oxide Signaling in Plants
    plants Editorial Nitric Oxide Signaling in Plants John T. Hancock Department of Applied Sciences, University of the West of England, Bristol BS16 1QY, UK; [email protected]; Tel.: +44-(0)117-328-2475 Received: 3 November 2020; Accepted: 10 November 2020; Published: 12 November 2020 Abstract: Nitric oxide (NO) is an integral part of cell signaling mechanisms in animals and plants. In plants, its enzymatic generation is still controversial. Evidence points to nitrate reductase being important, but the presence of a nitric oxide synthase-like enzyme is still contested. Regardless, NO has been shown to mediate many developmental stages in plants, and to be involved in a range of physiological responses, from stress management to stomatal aperture closure. Downstream from its generation are alterations of the actions of many cell signaling components, with post-translational modifications of proteins often being key. Here, a collection of papers embraces the differing aspects of NO metabolism in plants. Keywords: nitrate reductase; nitration; nitric oxide; reactive oxygen species; stress responses; S-nitrosation; S-nitrosylation; SNO-reductase; thiol modification 1. Introduction Nitric oxide (NO) is now well acknowledged as an instrumental signaling molecule in both plants and animals [1]. First recognized as important as a signal in the control of vascular tone [2], its role in plants came to prominence in the late 1990s [3–5]. The forty years of research into NO in plants has just been highlighted by a review by Kolbert et al. [6]. In plants, NO has been found to be involved in a wide range of developmental stages and physiological responses.
    [Show full text]
  • A Nitric Oxide/Cysteine Interaction Mediates the Activation of Soluble Guanylate Cyclase
    A nitric oxide/cysteine interaction mediates the activation of soluble guanylate cyclase Nathaniel B. Fernhoffa,1, Emily R. Derbyshirea,1,2, and Michael A. Marlettaa,b,c,3 Departments of aMolecular and Cell Biology and bChemistry, University of California, Berkeley, CA 94720; and cCalifornia Institute for Quantitative Biosciences and Division of Physical Biosciences, Lawrence Berkeley National Laboratory, Berkeley, CA 94720 Contributed by Michael A. Marletta, October 1, 2009 (sent for review August 22, 2009) Nitric oxide (NO) regulates a number of essential physiological pro- high activity of the xsNO state rapidly reverts to the low activity of cesses by activating soluble guanylate cyclase (sGC) to produce the the 1-NO state. Thus, all three sGC states (basal, 1-NO, and xsNO) second messenger cGMP. The mechanism of NO sensing was previ- can be prepared and studied in vitro (7, 8). Importantly, these ously thought to result exclusively from NO binding to the sGC heme; results define two different states of purified sGC with heme bound however, recent studies indicate that heme-bound NO only partially NO (7, 8), one with a high activity and one with a low activity. activates sGC and additional NO is involved in the mechanism of Further evidence for a non-heme NO binding site was obtained maximal NO activation. Furthermore, thiol oxidation of sGC cysteines by blocking the heme site with the tight-binding ligand butyl results in the loss of enzyme activity. Herein the role of cysteines in isocyanide, and then showing that NO still activated the enzyme NO-stimulated sGC activity investigated. We find that the thiol mod- (14).
    [Show full text]
  • Nitro-L-Arginine Methyl Ester (L-NAME) Causes Limb Defects in Mouse Fetuses: Protective Effect of Acute Hyperoxia
    0031-3998/03/5401-0069 PEDIATRIC RESEARCH Vol. 54, No. 1, 2003 Copyright © 2003 International Pediatric Research Foundation, Inc. Printed in U.S.A. The Nitric Oxide Synthesis Inhibitor ␻ N -Nitro-L-Arginine Methyl Ester (L-NAME) Causes Limb Defects in Mouse Fetuses: Protective Effect of Acute Hyperoxia GIAN MARIO TIBONI, FRANCA GIAMPIETRO, AND CAMILLO DI GIULIO Sezione di Ostetricia e Ginecologia, Dipartimento di Medicina e Scienze dell’Invecchiamento [G.M.T., F.G.], and Sezione di Fisiologia, Dipartimento di Scienze Biomediche [C.d.G.], Facoltà di Medicina e Chirurgia, Università “G. d’Annunzio”, Chieti, Italy. ABSTRACT In the present study the relationship between exposure to the teratogenesis was investigated. To this aim, a group of L-NAME– ␻ nitric oxide synthesis inhibitor N -nitro-L-arginine methyl ester treated animals (90 mg/kg s.c. on gestation d 14) were exposed (L-NAME) and the induction of limb defects, with respect to to 98 to 100% O2 for 12 h. L-NAME–treated mice breathing stage specificity and dose dependency, was investigated in the room air served as positive controls. In response to hyperoxia, a mouse. ICR (CD-1) mice were dosed s.c with L-NAME at 50 or significant decrement of L-NAME–induced limb defects was 90 mg/kg on gestation d 12, 13, 14, 15, or 16. A group of animals found. This study characterizes for the first time the teratogenic treated with vehicle on gestation d 14 served as control. Uterine capacity of L-NAME in the mouse. Results obtained with hyper- contents were evaluated for teratogenesis on gestation d 18.
    [Show full text]
  • Influence of Functional Variant of Neuronal Nitric Oxide Synthase on Impulsive Behaviors in Humans
    ORIGINAL ARTICLE Influence of Functional Variant of Neuronal Nitric Oxide Synthase on Impulsive Behaviors in Humans Andreas Reif, MD; Christian P. Jacob, MD; Dan Rujescu, MD; Sabine Herterich, PhD; Sebastian Lang, MD; Lise Gutknecht, PhD; Christina G. Baehne, Dipl-Psych; Alexander Strobel, PhD; Christine M. Freitag, MD; Ina Giegling, MD; Marcel Romanos, MD; Annette Hartmann, MD; Michael Rösler, MD; Tobias J. Renner, MD; Andreas J. Fallgatter, MD; Wolfgang Retz, MD; Ann-Christine Ehlis, PhD; Klaus-Peter Lesch, MD Context: Human personality is characterized by sub- Main Outcome Measures: For the association stud- stantial heritability but few functional gene variants have ies, the major outcome criteria were phenotypes rel- been identified. Although rodent data suggest that the evant to impulsivity, namely, the dimensional pheno- neuronal isoform of nitric oxide synthase (NOS-I) modi- type conscientiousness and the categorical phenotypes fies diverse behaviors including aggression, this has not adult ADHD, aggression, and cluster B personality been translated to human studies. disorder. Objectives: To investigate the functionality of an NOS1 Results: A novel functional promoter polymorphism in promoter repeat length variation (NOS1 Ex1f variable NOS1 was associated with traits related to impulsivity, number tandem repeat [VNTR]) and to test whether it including hyperactive and aggressive behaviors. Specifi- is associated with phenotypes relevant to impulsivity. cally, the short repeat variant was more frequent in adult ADHD, cluster B personality disorder, and autoaggres- Design: Molecular biological studies assessed the cel- sive and heteroaggressive behavior. This short variant lular consequences of NOS1 Ex1f VNTR; association came along with decreased transcriptional activity of the studies were conducted to investigate the impact of this genetic variant on impulsivity; imaging genetics was ap- NOS1 exon 1f promoter and alterations in the neuronal plied to determine whether the polymorphism is func- transcriptome including RGS4 and GRIN1.
    [Show full text]
  • New Insights Into the Role of Soluble Guanylate Cyclase in Blood Pressure Regulation
    New insights into the role of soluble guanylate cyclase in blood pressure regulation The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Buys, Emmanuel, and Patrick Sips. 2014. New Insights into the Role of Soluble Guanylate Cyclase in Blood Pressure Regulation. Current Opinion in Nephrology and Hypertension 23, no. 2: 135–142. doi:10.1097/01.mnh.0000441048.91041.3a. Published Version doi:10.1097/01.mnh.0000441048.91041.3a Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:29731915 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA NIH Public Access Author Manuscript Curr Opin Nephrol Hypertens. Author manuscript; available in PMC 2015 March 01. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Curr Opin Nephrol Hypertens. 2014 March ; 23(2): 135–142. doi:10.1097/01.mnh.0000441048.91041.3a. New Insights into the Role of Soluble Guanylate Cyclase in Blood Pressure Regulation Emmanuel Buys1 and Patrick Sips2 1Anesthesia Center for Critical Care Research, Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA 2Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA Abstract Purpose of review—Nitric oxide (NO) – soluble guanylate cyclase (sGC)-dependent signaling mechanisms have a profound effect on the regulation of blood pressure.
    [Show full text]
  • Non-Canonical Chemical Feedback Self-Limits Nitric Oxide-Cyclic GMP Signaling in Health and Disease Vu Thao-Vi Dao1,2,9, Mahmoud H
    www.nature.com/scientificreports OPEN Non-canonical chemical feedback self-limits nitric oxide-cyclic GMP signaling in health and disease Vu Thao-Vi Dao1,2,9, Mahmoud H. Elbatreek1,3,9 ✉ , Martin Deile4, Pavel I. Nedvetsky5, Andreas Güldner6, César Ibarra-Alvarado7, Axel Gödecke8 & Harald H. H. W. Schmidt1 ✉ Nitric oxide (NO)-cyclic GMP (cGMP) signaling is a vasoprotective pathway therapeutically targeted, for example, in pulmonary hypertension. Its dysregulation in disease is incompletely understood. Here we show in pulmonary artery endothelial cells that feedback inhibition by NO of the NO receptor, the cGMP forming soluble guanylate cyclase (sGC), may contribute to this. Both endogenous NO from endothelial NO synthase and exogenous NO from NO donor compounds decreased sGC protein and activity. This efect was not mediated by cGMP as the NO-independent sGC stimulator, or direct activation of cGMP- dependent protein kinase did not mimic it. Thiol-sensitive mechanisms were also not involved as the thiol-reducing agent N-acetyl-L-cysteine did not prevent this feedback. Instead, both in-vitro and in- vivo and in health and acute respiratory lung disease, chronically elevated NO led to the inactivation and degradation of sGC while leaving the heme-free isoform, apo-sGC, intact or even increasing its levels. Thus, NO regulates sGC in a bimodal manner, acutely stimulating and chronically inhibiting, as part of self-limiting direct feedback that is cGMP independent. In high NO disease conditions, this is aggravated but can be functionally recovered in a mechanism-based manner by apo-sGC activators that re-establish cGMP formation. Te nitric oxide (NO)-cGMP signaling pathway plays several essential roles in physiology, including cardio- pulmonary homeostasis1,2.
    [Show full text]
  • In Endothelial Cells, the Activation Or Stimulation of Soluble Guanylyl
    J Pharm Pharm Sci (www.cspsCanada.org) 21, 38 - 45, 2018 In Endothelial Cells, the Activation or Stimulation of Soluble Guanylyl Cyclase Induces the Nitric Oxide Production by a Mechanism Dependent of Nitric Oxide Synthase Activation Ariane Migliato Martinelli, Carla Nascimento dos Santos Rodrigues, Thiago Francisco de Moraes, Gerson Jhonatan Rodrigues. Departamento de Ciências Fisiológicas – Universidade Federal de São Carlos, São Carlos, SP, Brasil. Received October 29, 2017; Revised, January 12, 2018; Accepted, January 22, 2018; Published, January 22, 2018. ABSTRACT – Purpose. In endothelial cells, investigate if the soluble guanylate cyclase (sGC) activation or stimulation is able to potentiate the relaxation in vessels. Methods. Aortic and coronary rings with and without endothelium were placed in a myograph and cumulative concentration-effect curves for DETA-NO or ataciguat were performed. Nitric oxide (NO) were measured by fluorescence or by selective electrode in human umbilical endothelial cells (HUVECs) in response to some treatments, including ataciguat, 8-Br- cGMP and A23187. Results. The presence of the endothelium potentiated the relaxation induced by DETA- NO in aortic and coronary rings. In addition, in aortic rings the endothelium potentiated the relaxation induced by ataciguat. In the presence of nitric oxide synthase (NOS) inhibitor, the endothelium effect was abolished to DETA-NO or ataciguat, in both vessels. Ataciguat, 8-Br-cGMP and A23187 were able to induce NO production in HUVECs cells. In the presence of NOS inhibitor, the NO production induced by ataciguat and 8-Br-cGMP was abolished. Conclusions. Our results suggest that in aortic and coronary rings the endothelium potentiates the relaxation induced by activation or stimulation of sGC through a mechanism dependent of NOS activation.
    [Show full text]